Synapse

← Seth S. Martin

Papers by Seth S. Martin

Page 4 · newest first

  1. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia GuidelinesCirculation · 2018
  2. Increasing Physical Activity Amongst Overweight and Obese Cancer Survivors Using an Alexa-Based Intelligent Agent for Patient Coaching: Protocol for the Physical Activity by Technology Help (PATH) TrialJMIR Research Protocols · 2018
  3. Digital Health Innovation: A Toolkit to Navigate From Concept to Clinical TestingJMIR Cardio · 2018
  4. Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confoundingJournal of Lipid Research · 2018
  5. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) StudyJournal of the American Heart Association · 2017
  6. mActive-Smoke: A Prospective Observational Study Using Mobile Health Tools to Assess the Association of Physical Activity With Smoking Urges (Preprint)2017
  7. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol AccuracyCirculation · 2017
  8. Relationship of Lipids and Lipid-Lowering Medications With Cognitive FunctionAmerican Journal of Epidemiology · 2017
  9. Cardiovascular Disease Among Transgender Adults Receiving Hormone TherapyAnnals of Internal Medicine · 2017
  10. Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) StudyThe Journal of Clinical Endocrinology & Metabolism · 2017
  11. Accuracy of low-density lipoprotein cholesterol estimation at very low levelsBMC Medicine · 2017
  12. Physical Activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: The ARIC StudyThe Journal of Clinical Endocrinology & Metabolism · 2017
  13. Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patientsAIDS · 2017
  14. Vitamin D deficiency and non-lipid biomarkers of cardiovascular riskArchives of Medical Science · 2017
  15. Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive TherapyCirculation · 2016
  16. What to say and how to say itCurrent Opinion in Cardiology · 2016
  17. Expert opinion: the therapeutic challenges faced by statin intoleranceExpert Opinion on Pharmacotherapy · 2016
  18. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort StudiesJournal of the American Heart Association · 2016
  19. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic reviewEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2016
  20. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trialsPharmacological Research · 2016
  21. Lipoprotein(a) Levels in Patients With Abdominal Aortic AneurysmAngiology · 2016
  22. Validation of the Instant Blood Pressure Smartphone AppJAMA Internal Medicine · 2016
  23. Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboLipids in Health and Disease · 2016
  24. Triglycerides to high-density lipoprotein–cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetesCurrent Opinion in Endocrinology Diabetes and Obesity · 2016
  25. Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trialsScientific Reports · 2016
  26. Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community-based prevention clinicArchives of Medical Science · 2016
  27. Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial FibrillationJournal of the American College of Cardiology · 2015
  28. mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity PromotionJournal of the American Heart Association · 2015
  29. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH RegistryClinical Cardiology · 2015
  30. Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial InfarctionClinical Cardiology · 2015
  31. Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein CholesterolCirculation · 2015
  32. PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?Annals of Internal Medicine · 2015
  33. Cholesterol, Statins, and Dementia: What the Cardiologist Should KnowClinical Cardiology · 2015
  34. Cost-Effectiveness of Coronary Artery Calcium Testing for Coronary Heart and Cardiovascular Disease Risk Prediction to Guide Statin Allocation: The Multi-Ethnic Study of Atherosclerosis (MESA)PLoS ONE · 2015
  35. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic riskJournal of Hypertension · 2015
  36. Mapping Hyperlipidemia in Young Adulthood to Coronary RiskCirculation · 2015
  37. High-density lipoprotein and endothelial function in patients with myocardial infarction: Pieces in a puzzleAtherosclerosis · 2014
  38. Clinician's Guide to the Updated ABCs of Cardiovascular Disease PreventionJournal of the American Heart Association · 2014
  39. Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort StudiesEuropean Journal of Preventive Cardiology · 2014
  40. Improving lipid control following myocardial infarctionCurrent Opinion in Cardiology · 2014
  41. Non-cardiovascular effects associated with statinsBMJ · 2014
  42. HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborativeEuropean Heart Journal · 2014
  43. Current guidelines for high-density lipoprotein cholesterol in therapy and future directionsVascular Health and Risk Management · 2014
  44. Narrowing Sex Differences in Lipoprotein Cholesterol Subclasses Following Mid‐Life: The Very Large Database of Lipids (VLDL‐10B)Journal of the American Heart Association · 2014
  45. Neck Circumference Is Not Associated With Subclinical Atherosclerosis in Retired National Football League PlayersClinical Cardiology · 2014
  46. Concepts and Controversies: The 2013 American College of Cardiology/American Heart Association Risk Assessment and Cholesterol Treatment GuidelinesAnnals of Internal Medicine · 2014
  47. Atrial Septal Defects – Clinical Manifestations, Echo Assessment, and InterventionClinical Medicine Insights Cardiology · 2014
  48. Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid ProfileJAMA · 2013
  49. Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular DiseaseCirculation · 2013
  50. Very Large Database of Lipids: Rationale and DesignClinical Cardiology · 2013